Loading…
Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study
Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence o...
Saved in:
Published in: | International journal of molecular sciences 2023-12, Vol.24 (24), p.17292 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3 |
---|---|
cites | cdi_FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3 |
container_end_page | |
container_issue | 24 |
container_start_page | 17292 |
container_title | International journal of molecular sciences |
container_volume | 24 |
creator | Niemiec, Paweł Jarosz, Alicja Balcerzyk-Matić, Anna Iwanicka, Joanna Nowak, Tomasz Iwanicki, Tomasz Gierek, Marcin Kalita, Marcin Garczorz, Wojciech Francuz, Tomasz Górczyńska-Kosiorz, Sylwia Kania, Wojciech Szyluk, Karol |
description | Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the
gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of
gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five
gene polymorphisms (rs699947 A>C, rs2010963 C>G, rs1413711 C>T, rs3024998 C>T and rs3025021 C>T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters.
gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy. |
doi_str_mv | 10.3390/ijms242417292 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8235a0a81f474734a9b8f3c598bfde12</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8235a0a81f474734a9b8f3c598bfde12</doaj_id><sourcerecordid>2904659043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3</originalsourceid><addsrcrecordid>eNpdkc1vEzEQxS0Eom3gyBVZ4sJlwV-73uUWRWmIVIkIQiVOlu0dE0ebdbB3iXLvH45DSkV78Vie3zyN30PoDSUfOG_IR7_dJSaYoJI17Bm6pIKxgpBKPv_vfoGuUtoSwjgrm5fogteUN5TxS3S3gB4Gb_Gtjl4b3_nhiH2Pb-eL6yk-NfGyd90IvYWEhw3guXNgB_87t1LCweE19L1PeN6ZcMDrDUS9P-KDHzZ49XX1CU_x-hCKH6AjXsWQ9udhPAubEAf8bRjb4yv0wukuwev7OkHfr-fr2efi5stiOZveFFawaig4YUbK0rESqLCUSmtK01owknLRCAY1cCZdbSstK2YlNbwyRHJaV1KYVvMJWp5126C3ah_9TsejCtqrvw8h_lQ6ZjM6UDXjpSa6pk5IIbnQjakdt2VTG9dCtm6C3p-19jH8GiENaueTha7TPYQxKdaQsmQ5FZnRd0_QbRhjn396okRV5oNnqjhTNruUIriHBSlRp6jVo6gz__ZedTQ7aB_of9nyPz4qoqs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2904659043</pqid></control><display><type>article</type><title>Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study</title><source>PubMed (Medline)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Niemiec, Paweł ; Jarosz, Alicja ; Balcerzyk-Matić, Anna ; Iwanicka, Joanna ; Nowak, Tomasz ; Iwanicki, Tomasz ; Gierek, Marcin ; Kalita, Marcin ; Garczorz, Wojciech ; Francuz, Tomasz ; Górczyńska-Kosiorz, Sylwia ; Kania, Wojciech ; Szyluk, Karol</creator><creatorcontrib>Niemiec, Paweł ; Jarosz, Alicja ; Balcerzyk-Matić, Anna ; Iwanicka, Joanna ; Nowak, Tomasz ; Iwanicki, Tomasz ; Gierek, Marcin ; Kalita, Marcin ; Garczorz, Wojciech ; Francuz, Tomasz ; Górczyńska-Kosiorz, Sylwia ; Kania, Wojciech ; Szyluk, Karol</creatorcontrib><description>Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the
gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of
gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five
gene polymorphisms (rs699947 A>C, rs2010963 C>G, rs1413711 C>T, rs3024998 C>T and rs3025021 C>T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters.
gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms242417292</identifier><identifier>PMID: 38139123</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Angiogenesis ; Blood platelets ; Collagen ; Elbow ; Extracellular matrix ; Genes ; genetic polymorphism ; Genotype & phenotype ; Haplotypes ; Influence ; Patients ; Physiology ; platelet-rich plasma ; Polymorphism ; tendinopathy ; Tendons ; tennis elbow ; Vascular endothelial growth factor ; VEGFA</subject><ispartof>International journal of molecular sciences, 2023-12, Vol.24 (24), p.17292</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3</citedby><cites>FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3</cites><orcidid>0000-0002-6321-6090 ; 0000-0002-8686-9692 ; 0000-0003-0044-3162 ; 0000-0002-8159-6437 ; 0000-0002-3609-9554 ; 0000-0002-1113-7796 ; 0000-0001-6669-7216 ; 0000-0002-0853-9014 ; 0000-0002-5343-1205</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2904659043/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2904659043?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38139123$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niemiec, Paweł</creatorcontrib><creatorcontrib>Jarosz, Alicja</creatorcontrib><creatorcontrib>Balcerzyk-Matić, Anna</creatorcontrib><creatorcontrib>Iwanicka, Joanna</creatorcontrib><creatorcontrib>Nowak, Tomasz</creatorcontrib><creatorcontrib>Iwanicki, Tomasz</creatorcontrib><creatorcontrib>Gierek, Marcin</creatorcontrib><creatorcontrib>Kalita, Marcin</creatorcontrib><creatorcontrib>Garczorz, Wojciech</creatorcontrib><creatorcontrib>Francuz, Tomasz</creatorcontrib><creatorcontrib>Górczyńska-Kosiorz, Sylwia</creatorcontrib><creatorcontrib>Kania, Wojciech</creatorcontrib><creatorcontrib>Szyluk, Karol</creatorcontrib><title>Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the
gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of
gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five
gene polymorphisms (rs699947 A>C, rs2010963 C>G, rs1413711 C>T, rs3024998 C>T and rs3025021 C>T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters.
gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy.</description><subject>Angiogenesis</subject><subject>Blood platelets</subject><subject>Collagen</subject><subject>Elbow</subject><subject>Extracellular matrix</subject><subject>Genes</subject><subject>genetic polymorphism</subject><subject>Genotype & phenotype</subject><subject>Haplotypes</subject><subject>Influence</subject><subject>Patients</subject><subject>Physiology</subject><subject>platelet-rich plasma</subject><subject>Polymorphism</subject><subject>tendinopathy</subject><subject>Tendons</subject><subject>tennis elbow</subject><subject>Vascular endothelial growth factor</subject><subject>VEGFA</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkc1vEzEQxS0Eom3gyBVZ4sJlwV-73uUWRWmIVIkIQiVOlu0dE0ebdbB3iXLvH45DSkV78Vie3zyN30PoDSUfOG_IR7_dJSaYoJI17Bm6pIKxgpBKPv_vfoGuUtoSwjgrm5fogteUN5TxS3S3gB4Gb_Gtjl4b3_nhiH2Pb-eL6yk-NfGyd90IvYWEhw3guXNgB_87t1LCweE19L1PeN6ZcMDrDUS9P-KDHzZ49XX1CU_x-hCKH6AjXsWQ9udhPAubEAf8bRjb4yv0wukuwev7OkHfr-fr2efi5stiOZveFFawaig4YUbK0rESqLCUSmtK01owknLRCAY1cCZdbSstK2YlNbwyRHJaV1KYVvMJWp5126C3ah_9TsejCtqrvw8h_lQ6ZjM6UDXjpSa6pk5IIbnQjakdt2VTG9dCtm6C3p-19jH8GiENaueTha7TPYQxKdaQsmQ5FZnRd0_QbRhjn396okRV5oNnqjhTNruUIriHBSlRp6jVo6gz__ZedTQ7aB_of9nyPz4qoqs</recordid><startdate>20231209</startdate><enddate>20231209</enddate><creator>Niemiec, Paweł</creator><creator>Jarosz, Alicja</creator><creator>Balcerzyk-Matić, Anna</creator><creator>Iwanicka, Joanna</creator><creator>Nowak, Tomasz</creator><creator>Iwanicki, Tomasz</creator><creator>Gierek, Marcin</creator><creator>Kalita, Marcin</creator><creator>Garczorz, Wojciech</creator><creator>Francuz, Tomasz</creator><creator>Górczyńska-Kosiorz, Sylwia</creator><creator>Kania, Wojciech</creator><creator>Szyluk, Karol</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6321-6090</orcidid><orcidid>https://orcid.org/0000-0002-8686-9692</orcidid><orcidid>https://orcid.org/0000-0003-0044-3162</orcidid><orcidid>https://orcid.org/0000-0002-8159-6437</orcidid><orcidid>https://orcid.org/0000-0002-3609-9554</orcidid><orcidid>https://orcid.org/0000-0002-1113-7796</orcidid><orcidid>https://orcid.org/0000-0001-6669-7216</orcidid><orcidid>https://orcid.org/0000-0002-0853-9014</orcidid><orcidid>https://orcid.org/0000-0002-5343-1205</orcidid></search><sort><creationdate>20231209</creationdate><title>Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study</title><author>Niemiec, Paweł ; Jarosz, Alicja ; Balcerzyk-Matić, Anna ; Iwanicka, Joanna ; Nowak, Tomasz ; Iwanicki, Tomasz ; Gierek, Marcin ; Kalita, Marcin ; Garczorz, Wojciech ; Francuz, Tomasz ; Górczyńska-Kosiorz, Sylwia ; Kania, Wojciech ; Szyluk, Karol</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Angiogenesis</topic><topic>Blood platelets</topic><topic>Collagen</topic><topic>Elbow</topic><topic>Extracellular matrix</topic><topic>Genes</topic><topic>genetic polymorphism</topic><topic>Genotype & phenotype</topic><topic>Haplotypes</topic><topic>Influence</topic><topic>Patients</topic><topic>Physiology</topic><topic>platelet-rich plasma</topic><topic>Polymorphism</topic><topic>tendinopathy</topic><topic>Tendons</topic><topic>tennis elbow</topic><topic>Vascular endothelial growth factor</topic><topic>VEGFA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niemiec, Paweł</creatorcontrib><creatorcontrib>Jarosz, Alicja</creatorcontrib><creatorcontrib>Balcerzyk-Matić, Anna</creatorcontrib><creatorcontrib>Iwanicka, Joanna</creatorcontrib><creatorcontrib>Nowak, Tomasz</creatorcontrib><creatorcontrib>Iwanicki, Tomasz</creatorcontrib><creatorcontrib>Gierek, Marcin</creatorcontrib><creatorcontrib>Kalita, Marcin</creatorcontrib><creatorcontrib>Garczorz, Wojciech</creatorcontrib><creatorcontrib>Francuz, Tomasz</creatorcontrib><creatorcontrib>Górczyńska-Kosiorz, Sylwia</creatorcontrib><creatorcontrib>Kania, Wojciech</creatorcontrib><creatorcontrib>Szyluk, Karol</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niemiec, Paweł</au><au>Jarosz, Alicja</au><au>Balcerzyk-Matić, Anna</au><au>Iwanicka, Joanna</au><au>Nowak, Tomasz</au><au>Iwanicki, Tomasz</au><au>Gierek, Marcin</au><au>Kalita, Marcin</au><au>Garczorz, Wojciech</au><au>Francuz, Tomasz</au><au>Górczyńska-Kosiorz, Sylwia</au><au>Kania, Wojciech</au><au>Szyluk, Karol</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-12-09</date><risdate>2023</risdate><volume>24</volume><issue>24</issue><spage>17292</spage><pages>17292-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the
gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of
gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five
gene polymorphisms (rs699947 A>C, rs2010963 C>G, rs1413711 C>T, rs3024998 C>T and rs3025021 C>T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters.
gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38139123</pmid><doi>10.3390/ijms242417292</doi><orcidid>https://orcid.org/0000-0002-6321-6090</orcidid><orcidid>https://orcid.org/0000-0002-8686-9692</orcidid><orcidid>https://orcid.org/0000-0003-0044-3162</orcidid><orcidid>https://orcid.org/0000-0002-8159-6437</orcidid><orcidid>https://orcid.org/0000-0002-3609-9554</orcidid><orcidid>https://orcid.org/0000-0002-1113-7796</orcidid><orcidid>https://orcid.org/0000-0001-6669-7216</orcidid><orcidid>https://orcid.org/0000-0002-0853-9014</orcidid><orcidid>https://orcid.org/0000-0002-5343-1205</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2023-12, Vol.24 (24), p.17292 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_8235a0a81f474734a9b8f3c598bfde12 |
source | PubMed (Medline); Publicly Available Content Database (Proquest) (PQ_SDU_P3) |
subjects | Angiogenesis Blood platelets Collagen Elbow Extracellular matrix Genes genetic polymorphism Genotype & phenotype Haplotypes Influence Patients Physiology platelet-rich plasma Polymorphism tendinopathy Tendons tennis elbow Vascular endothelial growth factor VEGFA |
title | Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A25%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20Variability%20in%20VEGFA%20Gene%20Influences%20the%20Effectiveness%20of%20Tennis%20Elbow%20Therapy%20with%20PRP:%20A%20Two-Year%20Prospective%20Cohort%20Study&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Niemiec,%20Pawe%C5%82&rft.date=2023-12-09&rft.volume=24&rft.issue=24&rft.spage=17292&rft.pages=17292-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms242417292&rft_dat=%3Cproquest_doaj_%3E2904659043%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2904659043&rft_id=info:pmid/38139123&rfr_iscdi=true |